Market News AIOpen the app

SPRY stock news · ARS Pharmaceuticals

Stories about ARS Pharmaceuticals (SPRY) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for SPRY

Follow ARS Pharmaceuticals (SPRY) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for SPRY
Free on the App Store and Google Play, or on the web.
  1. Oct 12, 2026, 5:14 PM ET · Market

    12 health care companies saw big changes in their stock prices after the market closed on Monday.

    Neutral

    ARS Pharmaceuticals shares rose about 7%. The roundup gives no company news explaining the move, so it does not show a change in the company's business outlook.

  2. Aug 13, 2026, 5:22 PM ET · Results

    Q2 2026 results delivered by ARS Pharmaceuticals: Complete earnings call transcript available.

    Neutral

    ARS Pharmaceuticals' Q2 2026 earnings report reveals a doubling of market share and a strategic focus on targeted provider engagement, which could lead to increased adoption of their products and improved financial performance. The company's commitment to reducing operating expenses and achieving cash flow breakeven by the end of 2027 adds to a positive outlook for investors.